HLS Healius Limited
Healthcare · Diagnostics & Research
· website
· 3,699 employees
$0.38
52wk 0.30 – 1.07
Overall
—
Value
—
Growth
—
Health
—
Quality
—
Momentum
—
Dividend
—
Price
About Healius Limited
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$275.94M
P/E (trailing)
—
P/E (forward)
-791.67
EPS (trailing)
-0.76
Dividend yield
—
Payout ratio
0.0%
Beta
0.28
EV / EBITDA
28.18
Price / Book
0.50
ROE
-69.3%
Operating margin
1.1%
Net margin
-12.3%
Total cash
$51.60M
Total debt
$940.10M
Current ratio
0.58
Debt / Equity
1.69
Free cash flow
$495.66M
Avg volume
4.78M
Latest annual results
(FY ending 30 Jun 2025)
- Revenue$1.34B
- Gross profit$1.13B
- Operating income$200.00K
- Net income-$151.20M
- Diluted EPS-0.21
- Free cash flow$219.80M
- Net debt$854.60M